Butanediamide,N4-hydroxy-N1-[(1S)-1-(1H-indol-3-ylmethyl)-2-(methylamino)-2-oxoethyl]-2-(2-methylpropyl)-, (2R)-


Chemical Name: Butanediamide,N4-hydroxy-N1-[(1S)-1-(1H-indol-3-ylmethyl)-2-(methylamino)-2-oxoethyl]-2-(2-methylpropyl)-, (2R)-
CAS Number: 142880-36-2
Product Number: AG00350G(AGN-PC-0PT4CR)
Synonyms:
MDL No:
Molecular Formula: C20H28N4O4
Molecular Weight: 388.4607

Identification/Properties


Properties
MP:
>193°C (dec.)
Storage:
Inert atmosphere;2-8℃;
Form:
Solid
Stability:
Moisture Sensitive
Solubility:
Soluble in DMSO, and 100% ethanol.
Computed Properties
Molecular Weight:
388.468g/mol
XLogP3:
0.9
Hydrogen Bond Donor Count:
5
Hydrogen Bond Acceptor Count:
4
Rotatable Bond Count:
9
Exact Mass:
388.211g/mol
Monoisotopic Mass:
388.211g/mol
Topological Polar Surface Area:
123A^2
Heavy Atom Count:
28
Formal Charge:
0
Complexity:
554
Isotope Atom Count:
0
Defined Atom Stereocenter Count:
2
Undefined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
Covalently-Bonded Unit Count:
1
Compound Is Canonicalized:
Yes

Safety Information


GHS Pictogram:
Signal Word:
Warning
UN#:
-
Hazard Statements:
H302-H315-H319-H335
Precautionary Statements:
P261-P305+P351+P338
Class:
-
Packing Group:
-

NMR Spectrum


Other Analytical Data


Request for Quotation


Customer Feedback


Chemical Structure



Illomastat, also known as GM6001, is a potent inhibitor of matrix metalloproteinases (MMPs). MMPs are a group of enzymes that play a crucial role in tissue remodeling, wound healing, and various pathological processes such as cancer metastasis and inflammation. Illomastat has been widely used in chemical synthesis as a tool compound to study the role of MMPs in various biological processes.In chemical synthesis, Illomastat is used to inhibit the activity of MMPs present in biological samples or cell cultures. By inhibiting MMPs, Illomastat can help researchers understand the specific roles of these enzymes in disease progression and normal physiological processes. This inhibition can also lead to the discovery of new drug targets for conditions such as cancer and inflammatory diseases.Additionally, Illomastat's ability to inhibit MMPs has been utilized in the development of novel therapeutic agents. By studying the effects of Illomastat on MMP activity, researchers can identify potential drug candidates that target specific MMPs involved in disease pathways. Overall, Illomastat plays a crucial role in advancing our knowledge of MMP biology and its implications for drug discovery and development.